Imocitrelvir

DB21298ExperimentalSmall molecule

Imocitrelvir is a small molecule drug. The usage of the INN stem '-trelvir' in the name indicates that Imocitrelvir is a antiviral 3CL protease inhibitor. Imocitrelvir has a monoisotopic molecular...

Mechanism: Pharmacologically active on Genome polyprotein
Curator reviewed
Formula / weight: C₂₆H₂₉N₅O₇ · 523.546 g/mol (avg)
Code names: AG-7404 · V-7404

Resolves to

Compound

UNIIVQ1AN3OO42CAS343565-99-1ChEMBLCHEMBL141157ChEBI748567PubChem5280053

Structure

InChIKeyQCUZOJBYWQPLIN-BNMFZAHFSA-NSMILESCCOC(=O)\C=C\[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC#C)N1C=CC=C(NC(=O)C2=NOC(C)=C2)C1=O

Targets

P03303Genome polyproteinP0C6X7repP0DTD1rep

What you can answer from here — as of September 23, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Imocitrelvir, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account